Discovered genes reveal novel insights into biology of glaucoma
- Date:
- April 15, 2016
- Source:
- The Agency for Science, Technology and Research (A*STAR)
- Summary:
- New findings provide deeper understanding of the disease which affects mainly aging Asians, and open up new possibilities for the delivery of precision medicine.
- Share:
The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. Established in 2000 as a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards academic, economic and societal impact.
The key research areas at the GIS include Human Genetics, Infectious Diseases, Cancer Therapeutics and Stratified Oncology, Stem Cell and Regenerative Biology, Cancer Stem Cell Biology, Computational and Systems Biology, and Translational Research.
The genomics infrastructure at the GIS is utilised to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact.
Story Source:
Materials provided by The Agency for Science, Technology and Research (A*STAR). Note: Content may be edited for style and length.
Journal Reference:
- Tin Aung et al. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nature Genetics, 2016; DOI: 10.1038/ng.3540
Cite This Page: